Telemonitoring in diabetes: evolution of concepts and technologies, with a focus on results of the more recent studies
| العنوان: | Telemonitoring in diabetes: evolution of concepts and technologies, with a focus on results of the more recent studies |
|---|---|
| المؤلفون: | Jean Doucet, Sylvie Ervé, Bahougne T, M Hajjam, Laurent Meyer, Nathalie Jeandidier, Jawad Hajjam, Samy Talha, Abrar-Ahmad Zulfiqar, Hajjam El Hassani A, Emmanuel Andrès |
| المصدر: | Journal of Medicine and Life |
| بيانات النشر: | S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L, 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | Gerontology, Telemedicine, media_common.quotation_subject, Review, Disease, Type 2 diabetes, Appropriation, Quality of life (healthcare), Meta-Analysis as Topic, Diabetes mellitus, medicine, Humans, Empowerment, information and communication technology, media_common, Internet, diabetes, business.industry, telemonitoring, General Medicine, artificial intelligence, medicine.disease, Web, Diabetes Mellitus, Type 2, Information and Communications Technology, Quality of Life, business, chronic disease, Software, Systematic Reviews as Topic |
| الوصف: | This is a narrative review of telemonitoring (remote monitoring) projects and studies within the field of diabetes, with a focus on results of the more recent studies. Since the beginning of the 1990s, several telemedicine projects and studies focused on type 1 and type 2 diabetes. Over the last 5 years, numerous telemedicine projects based on connected objects and new information and communication technologies (ICT) (elements defining telemedicine 2.0) have emerged or are still under development. Two examples are the DIABETe and Telesage telemonitoring project which perfectly fits within the telemedicine 2.0 framework – the first to include artificial intelligence (AI) with MyPrediTM and DiabeoTM. Mainly, these projects and studies show that telemonitoring diabetic result in: improvements in control of blood glucose (BG) level and significant reduction in HbA1c (e.g., for Telescot et TELESAGE studies); positive impact on co-morbidities (arterial hypertension, weight, dyslipidemia) (e.g., for Telescot and DIABETe studies); better patient’s quality of life (e.g., for DIABETe study); positive impact on appropriation of the disease by patients and/or greater adherence to therapeutic and hygiene-dietary measures (e.g., The Utah Remote Monitoring Project); and at least, good receptiveness by patients and their empowerment. To date, the magnitude of its effects remains debatable, especially with the variation in patients’ characteristics (e.g., background, ability for self-management, medical condition), samples selection and approach for the treatment of control groups. All of the recent studies have been classified as “Moderate” to “High”. |
| تدمد: | 1844-3117 1844-122X |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ebf12ade0fcafb1d6b93b753e8f6d2 https://doi.org/10.25122/jml-2019-0006 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....63ebf12ade0fcafb1d6b93b753e8f6d2 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 18443117 1844122X |
|---|